Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals

Willem A Mak, Johannes G M Koeleman, David S Y Ong

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Article number105158
JournalJournal of Clinical Virology
Publication statusPublished - Jun 2022


  • Antibodies, Viral
  • COVID-19
  • Enzyme-Linked Immunospot Assay
  • Humans
  • SARS-CoV-2
  • T-Lymphocytes

Cite this